Brief: Cyclo Therapeutics Reports On 18 Month Expanded Access Program In Single Alzheimer's Patient
17/06/2020 13:09
June 17 (Reuters) - Ctd Holdings Inc CTDH.PK :
* CYCLO THERAPEUTICS REPORTS ON EIGHTEEN MONTH EXPANDED
ACCESS
PROGRAM IN SINGLE ALZHEIMER’S PATIENT
* CTD HOLDINGS INC - FAVORABLE RISK/BENEFIT ANALYSIS
OUTLINED IN
REPORT TO FDA
Source text for Eikon: ID:nBw5jvsXPa
Further company coverage: CTDH.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug